Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 10, 2020
3 Stocks to Buy if Coronavirus Second Wave Hits

3 Stocks to Buy if Coronavirus Second Wave Hits

Will there be a second wave? Scientists around the world are evaluating that question out of concern for public health. Investors want to know what it means for their portfolios. Which stocks will do well if Coronavirus spikes again? Tickeron can give you some insight on that. By analyzing market trends from the first wave, you can predict behavior for the second.

Technology stocks have performed at historic levels this year, but the market is severely overbought. Third quarter earnings reports may bring some of those numbers back to earth. To compensate for that, look at performance during Q1 and Q2, the height of global Covid shutdowns. You should also evaluate twelve-month trends and sales projections for Q3.

Netflix will Continue to Climb

On January 1st, Netflix (NFLX) was trading at $323.57 a share. It bottomed out on March 16th, when it hit a 2020 low of $298.84. The virus was just beginning to impact the US economy. By mid-April, the US and all other affected countries were completely shut down. Netflix stock benefitted from the stay-at-home orders. It’s currently selling for over $500 per share. 

Tickeron Screener has Netflix listed as a strong buy, with a projection of bullish behavior in both the one-week and one-month categories. The one-year historical analysis shows a market cap gain of 33.05%. Yahoo Finance predicts that sales growth for the third quarter will be 21.60%. That’s pretty good, but another Coronavirus wave could make that number climb even higher.

Technical analysis shows that Netflix is definitely a buy, but does fundamental analysis agree? Some might argue that Amazon Prime is gobbling up all the market share, but Netflix is producing original content at a faster rate. Viewers need fresh content. Movie theatres aren’t re-opening any time soon, if ever. Netflix is a definite buy if we see a second wave.   

Amazon is the 300-Pound Gorilla in 2020

Sure, Tesla (TSLA) has made a lot of noise this year, but we’re not betting on them to thrive during a second wave. It’s possible that they are the most overbought stock of 2020. Amazon (AMZN), on the other hand, is a beast. After an annual low of $1849.09 on March 20th, Jeff Bezos’ brainchild has skyrocketed to over $3000 per share, an all-time high. 

Needless to say, Tickeron has Amazon listed as a strong buy as 3 major fundamental metrics are signaling for a bullish momentum: Profit VS Risk rating, Price Growth rating, P/E Growth rating. 

Yahoo Finance predicts Q3 sales growth at 22.20%. The one-year market cap growth is an astounding 58.42%. Those are King Kong sized numbers. They also make Amazon an unstoppable force, even if Covid-19 strikes again. That second wave may actually turn their growth rate into a tsunami. 

You don’t have to be a financial analyst to see this one. Between Amazon Prime Video and their online shopping platform, the FAANG giant holds all the cards if the world goes into shut-down mode again. Even if that doesn’t happen, the way people shop and live their lives has changed forever after the first wave. Amazon is in the best position to take advantage of that.  

Zoom has Outpaced Google Meet

It’s rare to see Google lose a fight, but they can throw in the towel on this one. Zoom (ZM) has outperformed them this year in every way. Surprisingly, the area that Google Meet fell short was user experience. They were simply unprepared for the sheer volume of users that descended upon them when the world went virtual. Zoom was ready for it.  

In the past six months, Zoom’s stock has shown a gain of 267%. Q2 earnings actually exceeded expectations, which were fairly high. Tickeron has it listed as a buy, not a strong buy, but the 200% annual increase in market cap suggests it may be undervalued. Increased usage in the corporate and government sectors also indicate a spike will happen if a second wave hits.

Zoom’s movement in the past few weeks has been somewhat volatile, so if you’re trading, go long. Or buy some call options. The Aroon Indicator entered an uptrend on July 7th, so neither strategy will hurt you. Video conferencing is the preferred method of communication going forward and Zoom is the clear leader in the field. This stock will thrive in Q3. 

Current price $269.52 is above $255.90 the highest resistance line found by A.I. Throughout the month of 06/07/20 - 07/08/20, the price experienced a +28% Uptrend. During the week of 06/30/20 - 07/08/20, the stock enjoyed a +4% Uptrend growth.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In 61 of 72 similar cases where ZM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.

 

Use Tickeron Ticker for Additional Research

You can look up any publicly traded stock by going to the Tickeron Ticker page and entering the trading ticker for that security. Most of the information we’ve provided you here comes from those pages and Tickeron Screener. Check out both today to be a more informed trader or long-term investor. It’s free to get started and there are training and practice tools for the newbie.  

Related Ticker: ZM

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ZM in upward trend: price may jump up because it broke its lower Bollinger Band on September 18, 2026

ZM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 29 of 35 cases where ZM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ZM's RSI Indicator exited the oversold zone, 28 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on October 01, 2026. You may want to consider a long position or call options on ZM as a result. In 58 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

The Moving Average Convergence Divergence (MACD) for ZM just turned positive on October 01, 2026. Looking at past instances where ZM's MACD turned positive, the stock continued to rise in 28 of 40 cases over the following month. The odds of a continued upward trend are 70%.

Following a +6.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZM advanced for three days, in 188 of 291 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

ZM moved below its 50-day moving average on September 09, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ZM crossed bearishly below the 50-day moving average on September 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for ZM entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. ZM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.253) is normal, around the industry mean (51.456). P/E Ratio (8.106) is within average values for comparable stocks, (82.636). Projected Growth (PEG Ratio) (2.393) is also within normal values, averaging (3.135). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (5.562) is also within normal values, averaging (69.875).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM), Shopify Inc (NASDAQ:SHOP), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Datadog (NASDAQ:DDOG), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM), Autodesk (NASDAQ:ADSK).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 9.9B. The market cap for tickers in the group ranges from 39 to 244.09B. SAPGF holds the highest valuation in this group at 244.09B. The lowest valued company is STIXF at 39.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was -1%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 5%. RPGL experienced the highest price growth at 166%, while WCT experienced the biggest fall at -84%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 32% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 76
Price Growth Rating: 59
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
ZM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of video-first communications platform and application

Industry PackagedSoftware

Industry
Packaged Software
Address
55 Almaden Boulevard
Phone
+1 888 799-9666
Employees
7438
Web
https://www.zoom.com
Interact to see
Advertisement
Shares of Viridian Therapeutics (VRDN) are down approximately 32% in premarket trading on March 30, 2026, against a prior closing price of $27.39 on March 27, 2026, implying a premarket price near $18.63. The primary catalyst is the release of topline Phase 3 REVEAL-1 clinical trial data for elegrobart (VRDN-003) in patients with active thyroid eye disease (TED), long anticipated as the company's most critical near-term de-risking event.
SYY shares are trading approximately -6.40% lower in premarket trading on March 30, 2026, from a prior close of $81.80 to roughly $76.56. The primary catalyst is Sysco's announcement of a $29.1 billion definitive agreement to acquire Jetro Restaurant Depot, one of the nation's largest Cash & Carry food wholesalers.
Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies, primarily dendritic cell-based vaccines under its DCVax platform. The company's lead candidate, DCVax-L, targets glioblastoma multiforme (GBM), a lethal brain cancer, following completion of a Phase III trial. DCVax-Direct addresses inoperable solid tumors, with Phase I/II data available. NWBO operates in the competitive immunotherapy sector against players like large-cap biotechs, relying on a proprietary manufacturing process for cost-effective production.
FingerMotion, Inc. (FNGR) operates as a mobile data specialist, delivering mobile payment and recharge platform solutions mainly in China. The company's core revolves around telecommunication products and services, such as top-up recharges, data plans, SMS and MMS services, big data insights for consumer behavior analysis, and rich communication services (RCS) platforms. It also provides value-added products through partnerships with telecom providers and e-commerce platforms.
NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.
Xcel Energy Inc. (XEL) stands out as a major U.S. electric and natural gas utility, serving about 3.7 million electric and 2.2 million natural gas customers across eight states, mainly in the Midwest and West. The company focuses on regulated utilities, handling electricity generation, transmission, and distribution, while increasingly prioritizing renewable sources like wind and solar. Its model centers on steady, regulated returns from infrastructure investments, backed by rate cases and recovery mechanisms.
Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.
The ProShares UltraShort Bloomberg Natural Gas (KOLD) is a leveraged inverse exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the Bloomberg Natural Gas Subindex. This subindex reflects the natural gas segment of the commodities market by tracking futures contracts, primarily the second-month Henry Hub natural gas futures, weighted by liquidity and production. The fund does not invest directly in physical natural gas but uses derivatives like futures contracts and swaps to achieve its objective.
Shares of United Therapeutics (UTHR) are surging approximately +17% in premarket trading on Monday, March 30, 2026, with the market not yet open. The primary catalyst is a landmark Phase 3 clinical trial announcement: the TETON-1 pivotal study of nebulized Tyvaso® (treprostinil) met its primary endpoint for treating idiopathic pulmonary fibrosis (IPF), exceeding the already impressive treatment effects seen in the previously completed TETON-2 study.
AA shares are surging approximately +11.79% intraday on Monday, March 30, 2026, trading around $64.55 versus Friday's close of approximately $57.74. The primary catalyst is a supply shock in the global aluminum market: two major Middle Eastern aluminum producers — including Bahrain's Aluminium Bahrain (ALBA) — reported being struck by Iranian attacks, raising fears of significant output disruptions.
BSX shares are falling approximately 7.00% during Monday's session, trading near $64.33, down from Friday's close of $69.17. Primary catalyst: A "sell the news" reaction to Saturday's CHAMPION-AF clinical trial data for the WATCHMAN FLX™ device — results met all endpoints but contained meaningful caveats that are spooking investors.
Shares of CIEN are declining approximately -7.00% in Monday's session, with the stock trading near $369.68, versus a prior close of $397.50 on Friday, March 27, 2026. The primary catalyst is a broad, tariff-driven market sell-off as the Trump administration's escalating trade posture rattles investor sentiment across the technology and networking sectors heading into quarter-end.
Bloom Energy (BE) shares are trading down approximately 8.00% intraday on Monday, March 30, 2026, falling from a prior close of $133.24 to around $122.58, extending a turbulent stretch for the stock. The decline is driven by a confluence of broad macro selling pressure, renewed concerns around AI data center demand durability, and investor uncertainty following a CFO transition announced on Friday.
AAOI shares are trading down approximately 10.00% intraday on Monday, March 30, falling from a prior close of $98.21 to around $88.39. A broad-based market sell-off fueled by renewed tariff fears and macro uncertainty is putting acute pressure on technology and semiconductor-linked stocks.
In recent trading sessions, I've been watching the GraniteShares 2x Long DELL Daily ETF (DLLL) closely, as it shows heightened volatility that mirrors amplified movements in its underlying asset, Dell Technologies (DELL). From what I see, the ETF's performance reflects robust demand for AI-optimized servers and infrastructure solutions, propelling gains during periods of positive sentiment around DELL's earnings and strategic positioning. Recent weeks have seen sharp intraday swings, underscoring the leveraged nature of DLLL, which seeks 2x daily exposure before fees. Trading volumes have surged alongside broader interest in AI-related plays, though the ETF remains suitable primarily for short-term tactical positioning amid ongoing market cycles in technology hardware.
Planet Labs PBC (PL) shares fell 4.75% in the most recent completed session, closing at $30.86 versus a prior close of $32.40. Premarket indications today show PL down further, with quotes around $30.53–31.35, roughly 1–2% below Friday’s close, after having traded down as much as about 9% intraday last week.
SUNation Energy Inc. (SUNE) is indicated down about 19% in Monday’s premarket session after previously closing just under the mid‑$2 range in recent trading. The drop follows an exceptionally volatile March in which SUNE shares repeatedly surged on technical breakouts and debt‑restructuring news, including single‑day gains of 19–26%.
Micron Technology, Inc. (MU) fell 5.71% in the most recent completed session, dropping from a prior close of $357.21 to $336.84. The decline extends a pullback that began after MU’s post‑earnings surge in mid‑March, when the shares traded near a 52‑week high above $470 before sliding roughly 24–30% over subsequent sessions.
Karman Holdings Inc. (KRMN) fell 5.38% in the most recent completed session, closing at $84.07 after trading between $83.43 and $88.98. The pullback comes after a powerful multi‑month rally that saw the stock climb from a 52‑week low of about $25.02 to a high of $118.38, leaving it vulnerable to profit‑taking and valuation compression.
Lumentum Holdings Inc. (LITE) shares fell 4.93% in the most recent completed session, sliding from a prior close of $702.75 to $668.10. The drop comes after a massive AI-driven rally that pushed LITE up more than 1,000% over the past year and more than doubled year to date, leaving valuations stretched and vulnerable to profit‑taking.